Concepedia

R. Crabbé

RC

Statistics

Publications

10

Citations

610

H-Index

10

Active since

1996

Affiliations

Debiopharm (Switzerland)(Current)

Medical University of Białystok

University of Modena and Reggio Emilia

Janssen (Belgium)

Mount Sinai Hospital

R. Crabbé is an author at Debiopharm (Switzerland) specializing in medicine, viral hepatitis, and hepatitis.

Top concepts

Publications per year

1996–2011

10

Publications

10

The cyclophilin inhibitor Debio-025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus

Robert Flisiak, Andrzej Horban, Philippe Gallay et al. · Hepatology · 2008 · 222 citations

The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients #

Robert Flisiak, S.V. Feinman, Maciej Jabłkowski et al. · Hepatology · 2009 · 221 citations · Full text

4 ONCE DAILY ALISPORIVIR (DEB025) PLUS PEGIFNALFA2A/RIBAVIRIN RESULTS IN SUPERIOR SUSTAINED VIROLOGIC RESPONSE (SVR24) IN CHRONIC HEPATITIS C GENOTYPE 1 TREATMENT NAIVE PATIENTS

Robert Flisiak, Jean–Michel Pawlotsky, R. Crabbé et al. · Journal of Hepatology · 2011 · 54 citations · Full text

, , +8

143 EFFICACY AND SAFETY OF INCREASING DOSES OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A IN TREATMENT NAIVE CHRONIC HCV PATIENTS

Robert Flisiak, S.V. Feinman, Andrzej Horban et al. · Journal of Hepatology · 2008 · 25 citations · Full text

, , +6

Transdermal Permeation of Alniditan by Iontophoresis: In Vitro Optimization and Human Pharmacokinetic Data

A. Jadoul, J Mesens, Wim Caers et al. · Pharmaceutical Research · 1996 · 22 citations

1–5 of 10